This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita Releases 13 Kidney-Friendly Apple Recipes

DaVita®, a division of DaVita HealthCare Partners, Inc. (NYSE: DVA) and a leading provider of kidney care services, released 13 apple-based recipes to celebrate the season and the many varieties of this healthy, delicious fruit.

The 13 new recipes include desserts, side dishes and salads, from classic Apple Pie to Apple Cranberry Slaw with Celery Seed Dressing.

“There may be some truth to the old saying, 'An apple a day keeps the doctor away,’” said Sara Colman, a registered dietitian at DaVita. “Apples are packed with antioxidants, and several research studies have found that apples can lower the risk of heart disease and stroke.”

Colman says apples are also beneficial for people with kidney disease who follow a low-potassium diet—one medium apple contains only 158 mg of potassium and almost 4 grams of fiber, and apples arrive naturally in their own 100-calorie packages.

The recipes can be found on DaVita’s website at Hundreds of kidney-friendly recipes are available on, including a no-cost downloadable cookbook for those with diabetes and a kidney-friendly cookbook for those with CKD or end stage renal disease (ESRD). also offers “DaVita Diet Helper TM,” an online tool that helps those with CKD or ESRD plan menus, make shopping lists and track nutritional intake.

DaVita, DaVita Diet Helper and DaVita HealthCare Partners are trademarks or trademarks of DaVita Healthcare Partners Inc. All other trademarks are the property of their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of kidney care in the United States, DaVita delivers dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers located in the United States serving approximately 150,000 patients. The company also operated 24 outpatient dialysis centers located in five countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,781.26 -17.23 -0.10%
S&P 500 2,085.59 -4.52 -0.22%
NASDAQ 5,122.7910 -4.7340 -0.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs